4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
Authors
Keywords
-
Journal
Therapeutic Advances in Neurological Disorders
Volume 7, Issue 2, Pages 97-113
Publisher
SAGE Publications
Online
2013-12-21
DOI
10.1177/1756285613512712
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment
- (2017) Tiffany J. Braley et al. SLEEP
- Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis
- (2012) Arun V Krishnan et al. Multiple Sclerosis Journal
- Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)
- (2012) Andrew D. Goodman et al. Neurotherapeutics
- Dalfampridine: A new agent for symptomatic management of multiple sclerosis
- (2011) S. McDonald et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Dalfampridine in multiple sclerosis: From symptomatic treatment to immunomodulation
- (2011) Carmen Espejo et al. CLINICAL IMMUNOLOGY
- Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis
- (2011) Craig I. Coleman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
- (2011) Keith Hayes Neuropsychiatric Disease and Treatment
- Treatment of walking impairment in multiple sclerosis with dalfampridine
- (2011) Andrew R. Blight Therapeutic Advances in Neurological Disorders
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- Dalfampridine Extended Release
- (2010) Claudine M. Chwieduk et al. CNS DRUGS
- Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers
- (2009) Andrew R. Blight et al. CLINICAL THERAPEUTICS
- Sustained-release fampridine for multiple sclerosis
- (2009) Christopher T Bever et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sustained release oral fampridine in the treatment of multiple sclerosis
- (2009) Norman J Kachuck EXPERT OPINION ON PHARMACOTHERAPY
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Mental fatigue alters the pattern and increases the volume of cerebral activation required for a motor task in multiple sclerosis patients with fatigue
- (2008) M. C. Tartaglia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Dose comparison trial of sustained-release fampridine in multiple sclerosis
- (2008) A. D. Goodman et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now